<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Nieves W</submitter><funding>NIAID NIH HHS</funding><funding>Wellcome Trust</funding><funding>NIGMS NIH HHS</funding><pagination>4632-40</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4875814</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>196(11)</volume><pubmed_abstract>How the metabolic demand of parasitism affects immune-mediated resistance is poorly understood. Immunity against parasitic helminths requires M2 cells and IL-13, secreted by CD4(+) Th2 and group 2 innate lymphoid cells (ILC2), but whether certain metabolic enzymes control disease outcome has not been addressed. This study demonstrates that AMP-activated protein kinase (AMPK), a key driver of cellular energy, regulates type 2 immunity and restricts lung injury following hookworm infection. Mice with a selective deficiency in the AMPK catalytic α1 subunit in alveolar macrophages and conventional dendritic cells produced less IL-13 and CCL17 and had impaired expansion of ILC2 in damaged lung tissue compared with wild-type controls. Defective type 2 responses were marked by increased intestinal worm burdens, exacerbated lung injury, and increased production of IL-12/23p40, which, when neutralized, restored IL-13 production and improved lung recovery. Taken together, these data indicate that defective AMPK activity in myeloid cells negatively impacts type 2 responses through increased IL-12/23p40 production. These data support an emerging concept that myeloid cells and ILC2 can coordinately regulate tissue damage at mucosal sites through mechanisms dependent on metabolic enzyme function.</pubmed_abstract><journal>Journal of immunology (Baltimore, Md. : 1950)</journal><pubmed_title>Myeloid-Restricted AMPKα1 Promotes Host Immunity and Protects against IL-12/23p40-Dependent Lung Injury during Hookworm Infection.</pubmed_title><pmcid>PMC4875814</pmcid><funding_grant_id>R01 AI095289</funding_grant_id><funding_grant_id>R01 GM083204</funding_grant_id><funding_grant_id>P30 AI027763</funding_grant_id><funding_grant_id>T32 AI007334</funding_grant_id><pubmed_authors>Nieves W</pubmed_authors><pubmed_authors>Herbert DR</pubmed_authors><pubmed_authors>Hung LY</pubmed_authors><pubmed_authors>Viollet B</pubmed_authors><pubmed_authors>Oniskey TK</pubmed_authors><pubmed_authors>Boon L</pubmed_authors><pubmed_authors>Foretz M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Myeloid-Restricted AMPKα1 Promotes Host Immunity and Protects against IL-12/23p40-Dependent Lung Injury during Hookworm Infection.</name><description>How the metabolic demand of parasitism affects immune-mediated resistance is poorly understood. Immunity against parasitic helminths requires M2 cells and IL-13, secreted by CD4(+) Th2 and group 2 innate lymphoid cells (ILC2), but whether certain metabolic enzymes control disease outcome has not been addressed. This study demonstrates that AMP-activated protein kinase (AMPK), a key driver of cellular energy, regulates type 2 immunity and restricts lung injury following hookworm infection. Mice with a selective deficiency in the AMPK catalytic α1 subunit in alveolar macrophages and conventional dendritic cells produced less IL-13 and CCL17 and had impaired expansion of ILC2 in damaged lung tissue compared with wild-type controls. Defective type 2 responses were marked by increased intestinal worm burdens, exacerbated lung injury, and increased production of IL-12/23p40, which, when neutralized, restored IL-13 production and improved lung recovery. Taken together, these data indicate that defective AMPK activity in myeloid cells negatively impacts type 2 responses through increased IL-12/23p40 production. These data support an emerging concept that myeloid cells and ILC2 can coordinately regulate tissue damage at mucosal sites through mechanisms dependent on metabolic enzyme function.</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Jun</publication><modification>2024-11-13T10:53:22.186Z</modification><creation>2019-03-27T02:14:15Z</creation></dates><accession>S-EPMC4875814</accession><cross_references><pubmed>27183598</pubmed><doi>10.4049/jimmunol.1502218</doi></cross_references></HashMap>